Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis

Intensive Care Medicine

Volumn 35, Issue 1, 2009, Pages 55-62

  Guery, Benoît P ^a   Arendrup, Maiken C ^b   Auzinger, Georg ^c   Azoulay, Élie ^d   Borges Sá, Márcio ^e   Johnson, Elizabeth M ^f   Müller, Eckhard ^g   Putensen, Christian ^h   Rotstein, Coleman ⁱ   Sganga, Gabriele ^j   Venditti, Mario ^k   Zaragoza Crespo, Rafael ^l   Kullberg, Bart Jan ^m  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b STATENS SERUM INSTITUT   (Denmark)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d SAINT LOUIS HOSPITAL   (France)

^e HOSPITAL SON LLÀTZER   (Spain)

^f NHS BLOOD AND TRANSPLANT   (United Kingdom)

^g RUHR UNIVERSITY BOCHUM   (Germany)

^h UNIVERSITY OF BONN   (Germany)

ⁱ TORONTO GENERAL HOSPITAL   (Canada)

^j CATHOLIC UNIVERSITY   (Italy)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

^l HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^m RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Antifungal; Azole; Candida; Candidiasis; Echinocandins; Intensive care; Invasive candidiasis; Polyenes

Indexed keywords

1,3 BETA GLUCAN SYNTHASE;

BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDEMIA; CANDIDIASIS; HUMAN; INTENSIVE CARE UNIT; ISOLATION PROCEDURE; LABORATORY DIAGNOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR;

BIOLOGICAL MARKERS; CANDIDIASIS; CROSS INFECTION; EUROPE; FUNGEMIA; HUMANS; INTENSIVE CARE UNITS; PREVALENCE; TURKEY;

EID: 58549105895     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-008-1338-7     Document Type: Review

References (56)

1. H Wisplinghoff T Bischoff SM Tallent H Seifert RP Wenzel MB Edmond 2004 Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 309 317
2. MA Pfaller DJ Diekema 2007 Epidemiology of invasive candidiasis: a persistent public health problem Clin Microbiol Rev 20 133 163
3. MC Arendrup K Fuursted B Gahrn-Hansen IM Jensen JD Knudsen B Lundgren HC Schonheyder M Tvede 2005 Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility J Clin Microbiol 43 4434 4440
4. MC Arendrup K Fuursted B Gahrn-Hansen HC Schonheyder JD Knudsen IM Jensen B Bruun JJ Christensen HK Johansen 2008 Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility Clin Microbiol Infect 14 487 494
5. E Poikonen O Lyytikainen VJ Anttila P Ruutu 2003 Candidemia in Finland, 1995-1999 Emerg Infect Dis 9 985 990
6. R Luzzati B Allegranzi L Antozzi L Masala E Pegoraro A Azzini E Concia 2005 Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital Clin Microbiol Infect 11 908 913
7. ME Bougnoux G Kac P Aegerter C d'Enfert JY Fagon 2008 Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome Intensive Care Med 34 292 299
8. SB Wey M Mori MA Pfaller RF Woolson RP Wenzel 1988 Hospital-acquired candidemia. The attributable mortality and excess length of stay Arch Intern Med 148 2642 2645
9. AM Rentz MT Halpern R Bowden 1998 The impact of candidemia on length of hospital stay, outcome, and overall cost of illness Clin Infect Dis 27 781 788
10. PM Olaechea M Palomar C Leon-Gil F Alvarez-Lerma R Jorda J Nolla-Salas MA Leon-Regidor 2004 Economic impact of Candida colonization and Candida infection in the critically ill patient Eur J Clin Microbiol Infect Dis 23 323 330
11. O Marchetti J Bille U Fluckiger P Eggimann C Ruef J Garbino T Calandra MP Glauser MG Tauber D Pittet 2004 Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000 Clin Infect Dis 38 311 320
12. O Gudlaugsson S Gillespie K Lee BJ Vande J Hu S Messer L Herwaldt M Pfaller D Diekema 2003 Attributable mortality of nosocomial candidemia, revisited Clin Infect Dis 37 1172 1177
13. S Hadley WW Lee R Ruthazer SA Nasraway Jr. 2002 Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients Crit Care Med 30 1808 1814
14. ME Falagas KE Apostolou VD Pappas 2006 Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies Eur J Clin Microbiol Infect Dis 25 419 425
15. M Tumbarello B Posteraro EM Trecarichi B Fiori M Rossi R Porta DK de Gaetano M La Sorda T Spanu G Fadda R Cauda M Sanguinetti 2007 Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia J Clin Microbiol 45 1843 1850
16. G Dimopoulos F Ntziora G Rachiotis A Armaganidis ME Falagas 2008 Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome Anesth Analg 106 523 529
17. S Blot K Vandewoude E Hoste J Poelaert F Colardyn 2001 Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata J Hosp Infect 47 308 313
18. C Viscoli C Girmenia A Marinus L Collette P Martino B Vandercam C Doyen B Lebeau D Spence V Krcmery B De Pauw F Meunier 1999 Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC) Clin Infect Dis 28 1071 1079
19. G Kovacicova Y Krupova M Lovaszova A Roidova J Trupl A Liskova J Hanzen P Milosovic M Lamosova L Macekova Z Szovenyiova A Purgelova T Obertik J Bille V Krcmery 2000 Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia? J Infect Chemother 6 216 221
20. MJ Klevay EJ Ernst JL Hollanbaugh JG Miller MA Pfaller DJ Diekema 2008 Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection Diag Microbiol Infect Dis 60 273 277
21. SH Aliyu DA Enoch II Abubakar R Ali AJ Carmichael M Farrington AM Lever 2006 Candidaemia in a large teaching hospital: a clinical audit QJM 99 655 663
22. M Bassetti E Righi A Costa R Fasce MP Molinari R Rosso FB Pallavicini C Viscoli 2006 Epidemiological trends in nosocomial candidemia in intensive care BMC Infect Dis 6 21
23. AF Shorr DR Lazarus JH Sherner WL Jackson M Morrel VJ Fraser MH Kollef 2007 Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia Crit Care Med 35 1077 1083
24. CC Kibbler S Seaton RA Barnes WR Gransden RE Holliman EM Johnson JD Perry DJ Sullivan JA Wilson 2003 Management and outcome of bloodstream infections due to Candida species in England and Wales J Hosp Infect 54 18 24
25. AM Tortorano J Peman H Bernhardt L Klingspor CC Kibbler O Faure E Biraghi E Canton K Zimmermann S Seaton R Grillot 2004 Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study Eur J Clin Microbiol Infect Dis 23 317 322
26. F Comert C Kulah E Aktas O Eroglu N Ozlu 2007 Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period Mycoses 50 52 57
27. M Laverdiere AC Labbe C Restieri C Rotstein D Heyland S Madger T Stewart 2007 Susceptibility patterns of Candida species recovered from Canadian intensive care units J Crit Care 22 245 250
28. C Leon S Ruiz-Santana P Saavedra B Almirante J Nolla-Salas F Alvarez-Lerma J Garnacho-Montero MA Leon 2006 A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization Crit Care Med 34 730 737
29. U Fluckiger O Marchetti J Bille P Eggimann S Zimmerli A Imhof J Garbino C Ruef D Pittet M Tauber M Glauser T Calandra 2006 Treatment options of invasive fungal infections in adults Swiss Med Wkly 136 447 463
30. M Morrell VJ Fraser MH Kollef 2005 Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality Antimicrob Agents Chemother 49 3640 3645
31. BJ Spellberg SG Filler JE Edwards Jr. 2006 Current treatment strategies for disseminated candidiasis Clin Infect Dis 42 244 251
32. NI Paphitou L Ostrosky-Zeichner JH Rex 2005 Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials Med Mycol 43 235 243
33. L Ostrosky-Zeichner C Sable J Sobel BD Alexander G Donowitz V Kan CA Kauffman D Kett RA Larsen V Morrison M Nucci PG Pappas ME Bradley S Major L Zimmer D Wallace WE Dismukes JH Rex 2007 Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting Eur J Clin Microbiol Infect Dis 26 271 276
34. HM Blumberg WR Jarvis JM Soucie JE Edwards JE Patterson MA Pfaller MS Rangel-Frausto MG Rinaldi L Saiman RT Wiblin RP Wenzel 2001 Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey Clin Infect Dis 33 177 186
35. JD Sobel JH Rex 2001 Invasive candidiasis: turning risk into a practical prevention policy? Clin Infect Dis 33 187 190
36. SB Wey M Mori MA Pfaller RF Woolson RP Wenzel 1989 Risk factors for hospital-acquired candidemia. A matched case-control study Arch Intern Med 149 2349 2353
37. JJ De Waele D Vogelaers S Blot F Colardyn 2003 Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy Clin Infect Dis 37 208 213
38. H Dupont C Paugam-Burtz C Muller-Serieys L Fierobe D Chosidow JP Marmuse J Mantz JM Desmonts 2002 Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients Arch Surg 137 1341 1346
39. C Agvald-Ohman L Klingspor H Hjelmqvist C Edlund 2007 Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome Scand J Infect Dis 40 145 153
40. P Munoz A Burillo E Bouza 2000 Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit Int J Antimicrob Agents 15 83 90
41. RK Pelz PA Lipsett SM Swoboda M Diener-West JM Hammond CW Hendrix 2000 The diagnostic value of fungal surveillance cultures in critically ill patients Surg Infect (Larchmt) 1 273 281
42. AS Michalopoulos S Geroulanos SD Mentzelopoulos 2003 Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients Chest 124 2244 2255
43. MG Petri J Konig HP Moecke HJ Gramm H Barkow P Kujath R Dennhart H Schafer N Meyer P Kalmar P Thulig J Muller H Lode 1997 Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research Intensive Care Med 23 317 325
44. F Stephan MS Bah C Desterke S Rezaiguia-Delclaux F Foulet P Duvaldestin S Bretagne 2002 Molecular diversity and routes of colonization of Candida albicans in a surgical intensive care unit, as studied using microsatellite markers Clin Infect Dis 35 1477 1483
45. O Eloy S Marque F Botterel F Stephan JM Costa V Lasserre S Bretagne 2006 Uniform distribution of three Candida albicans microsatellite markers in two French ICU populations supports a lack of nosocomial cross-contamination BMC Infect Dis 6 162
46. D Pittet M Monod PM Suter E Frenk R Auckenthaler 1994 Candida colonization and subsequent infections in critically ill surgical patients Ann Surg 220 751 758
47. L Ostrosky-Zeichner BD Alexander DH Kett J Vazquez PG Pappas F Saeki PA Ketchum J Wingard R Schiff H Tamura MA Finkelman JH Rex 2005 Multicenter clinical evaluation of the (1->3) beta-d-glucan assay as an aid to diagnosis of fungal infections in humans Clin Infect Dis 41 654 659
48. Y Fukazawa 1989 Antigenic structure of Candida albicans. Immunochemical basis of the serologic specificity of the mannans in yeasts Immunol Ser 47 37 62
49. D Poulain R Robert F Mesnard B Sendid G Lepage D Camus 1997 Clearances of Candida albicans-derived alpha- and beta-linked mannose residues in sera from patients with candidiasis Eur J Clin Microbiol Infect Dis 16 16 20
50. B Sendid M Tabouret JL Poirot D Mathieu J Fruit D Poulain 1999 New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis J Clin Microbiol 37 1510 1517
51. B Sendid JL Poirot M Tabouret A Bonnin D Caillot D Camus D Poulain 2002 Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species J Med Microbiol 51 433 442
52. B Sendid T Jouault R Coudriau D Camus F Odds M Tabouret D Poulain 2004 Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis J Clin Microbiol 42 164 171
53. MD Moragues N Ortiz JR Iruretagoyena JC Garcia-Ruiz E Amutio A Rojas J Mendoza G Quindos J Ponton-San Emeterio 2004 Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis Enferm Infecc Microbiol Clin 22 83 88
54. A Lain N Elguezabal S Brena JC Garcia-Ruiz A Del Palacio MD Moragues J Ponton 2007 Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1 BMC Microbiol 7 35
55. T Arishima J Takezawa 2006 Use of PCR based diagnosis for common invasive fungal infections in the intensive care unit Nippon Ishinkin Gakkai Zasshi 47 283 288
56. R McMullan L Metwally PV Coyle S Hedderwick B McCloskey HJ O'Neill CC Patterson G Thompson CH Webb RJ Hay 2008 A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults Clin Infect Dis 46 890 896